• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与冒烟型多发性骨髓瘤相关的坏死性黄色肉芽肿:对环磷酰胺、地塞米松和沙利度胺治疗反应良好。

Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide.

作者信息

Mello Renan Bernardes de, Vale Everton Carlos Siviero do

机构信息

Dermatology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

An Bras Dermatol. 2019 Jul 29;94(3):337-340. doi: 10.1590/abd1806-4841.20198500.

DOI:10.1590/abd1806-4841.20198500
PMID:31365665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6668937/
Abstract

Necrobiotic xanthogranuloma is a rare chronic condition, belonging to the group C non-Langerhans cell histiocytoses, which is relevant due to the possibility of extracutaneous involvement and association with systemic diseases, particularly hematologic malignancies. The case reported here was only diagnosed after nine years of evolution and was associated with plasma cell dyscrasia. After treatment with cyclophosphamide, dexamethasone, and thalidomide, there was a reduction of cutaneous lesions and serum levels of monoclonal protein.

摘要

坏死性黄色肉芽肿是一种罕见的慢性疾病,属于C组非朗格汉斯细胞组织细胞增多症,因其可能累及皮肤外以及与全身性疾病尤其是血液系统恶性肿瘤相关而受到关注。此处报告的病例在病程九年之后才得以确诊,且与浆细胞异常增生有关。经环磷酰胺、地塞米松和沙利度胺治疗后,皮肤损害及单克隆蛋白的血清水平有所降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/3f0b673248e2/abd-94-03-0337-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/25d6752d78e2/abd-94-03-0337-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/4e38da07a08c/abd-94-03-0337-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/536b2b694c3d/abd-94-03-0337-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/523ec5125a59/abd-94-03-0337-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/62537f821e6a/abd-94-03-0337-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/3f0b673248e2/abd-94-03-0337-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/25d6752d78e2/abd-94-03-0337-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/4e38da07a08c/abd-94-03-0337-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/536b2b694c3d/abd-94-03-0337-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/523ec5125a59/abd-94-03-0337-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/62537f821e6a/abd-94-03-0337-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5313/6668937/3f0b673248e2/abd-94-03-0337-g06.jpg

相似文献

1
Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide.与冒烟型多发性骨髓瘤相关的坏死性黄色肉芽肿:对环磷酰胺、地塞米松和沙利度胺治疗反应良好。
An Bras Dermatol. 2019 Jul 29;94(3):337-340. doi: 10.1590/abd1806-4841.20198500.
2
Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.沙利度胺和地塞米松治疗伴单克隆丙种球蛋白病的坏死性黄色肉芽肿患者的完全缓解:病例报告及文献复习。
Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):298-302. doi: 10.1016/j.clml.2011.03.020. Epub 2011 Apr 20.
3
[Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone].硼替佐米、来那度胺和地塞米松诱导单克隆免疫球蛋白消失后坏死性黄色肉芽肿完全缓解
Vnitr Lek. 2021 Winter;67(6):352-356.
4
Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation.伴有副蛋白血症且初发时无眶周受累的四肢坏死性黄色肉芽肿。
Cutis. 2012 Jan;89(1):41-4.
5
Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone.与单克隆丙种球蛋白病相关的坏死性黄色肉芽肿:来那度胺和地塞米松治疗成功
Ann Hematol. 2016 Mar;95(4):671-2. doi: 10.1007/s00277-016-2604-3. Epub 2016 Jan 27.
6
Necrobiotic xanthogranuloma.
Dermatol Online J. 2012 Dec 15;18(12):30.
7
Necrobiotic Xanthogranuloma.
Mayo Clin Proc. 2021 Sep;96(9):2432-2434. doi: 10.1016/j.mayocp.2021.05.012.
8
Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.采用新型多发性骨髓瘤疗法成功治疗眶周坏死性黄色肉芽肿。
Clin Adv Hematol Oncol. 2013 Oct;11(10):678-80.
9
Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration.坏死性黄色肉芽肿作为双侧慢性腿部溃疡屈光不正的罕见病因。
Int J Low Extrem Wounds. 2012 Dec;11(4):293-5. doi: 10.1177/1534734612465434.
10
Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin.成功用静脉注射免疫球蛋白治疗坏死性黄色肉芽肿。
J Cutan Med Surg. 2013 Sep-Oct;17(5):347-50. doi: 10.2310/7750.2013.13012.

引用本文的文献

1
Adult orbital xanthogranuloma: long-term follow-up of treated cases.成人眼眶黄色肉芽肿:治疗病例的长期随访。
Eye (Lond). 2023 Aug;37(12):2475-2481. doi: 10.1038/s41433-022-02357-z. Epub 2022 Dec 16.
2
Systemic therapy of necrobiotic xanthogranuloma: a systematic review.坏死性黄色肉芽肿的系统性治疗:系统评价。
Orphanet J Rare Dis. 2022 Mar 24;17(1):132. doi: 10.1186/s13023-022-02291-z.

本文引用的文献

1
Necrobiotic xanthogranuloma: a 30-year single-center experience.坏死性黄色肉芽肿:30 年单中心经验。
Ann Hematol. 2018 Aug;97(8):1471-1479. doi: 10.1007/s00277-018-3301-1. Epub 2018 Mar 22.
2
Necrobiotic xanthogranuloma treated with lenalidomide.来那度胺治疗坏死性黄色肉芽肿。
Clin Exp Dermatol. 2018 Apr;43(3):345-347. doi: 10.1111/ced.13293. Epub 2017 Oct 19.
3
The clinical spectrum of xanthomatous lesions of the eyelids.眼睑黄色瘤病变的临床谱。
Int J Dermatol. 2017 Oct;56(10):981-992. doi: 10.1111/ijd.13637. Epub 2017 May 13.
4
Treatment of necrobiotic xanthogranuloma - a systematic review.坏死性黄色肉芽肿的治疗——一项系统评价
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):221-235. doi: 10.1111/jdv.13786. Epub 2016 Jul 19.
5
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.与单克隆丙种球蛋白病相关的坏死性黄色肉芽肿患者的临床特征及治疗结果
Clin Lymphoma Myeloma Leuk. 2016 Aug;16(8):447-52. doi: 10.1016/j.clml.2016.04.009. Epub 2016 May 5.
6
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.巨噬细胞-树突状细胞谱系组织细胞增多症和肿瘤的修订分类
Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10.
7
Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation.坏死性黄色肉芽肿:17例病例回顾,重点关注临床与病理的相关性
Arch Dermatol. 2009 Mar;145(3):279-84. doi: 10.1001/archdermatol.2008.583.
8
Necrobiotic xanthogranuloma.坏死性黄色肉芽肿
Int J Dermatol. 2009 Jan;48(1):1-10. doi: 10.1111/j.1365-4632.2009.03912.x.
9
Necrobiotic xanthogranuloma.坏死性黄色肉芽肿
Semin Cutan Med Surg. 2007 Jun;26(2):108-13. doi: 10.1016/j.sder.2007.02.008.